Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the trial is to check if inhaled glucocorticosteroids (iGCS) have influence on bone condition (if iGCS increases risk of osteoporosis and bone fraction) in children with asthma.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Lodz; Medical Universtity of Lodz
• Treatments: Albuterol; Budesonide; Cholecalciferol; Montelukast; Vitamins

Criteria

Inclusion Criteria:

• Allergic only to house dust mites

• Never treated chronically (longer than at least 3 months) with anti-asthmatic drugs

• Newly-diagnosed or non-treated asthma

• Must be able to inhale drugs

Exclusion Criteria:

• Other allergic diseases requiring treatment with glucocorticosteroids

• Other chronic diseases

• Asthma exacerbation

• Pregnancy